146 related articles for article (PubMed ID: 14763545)
1. Treatment of benign bone lesions with an injectable calcium sulfate-based bone graft substitute.
Kelly CM; Wilkins RM
Orthopedics; 2004 Jan; 27(1 Suppl):s131-5. PubMed ID: 14763545
[TBL] [Abstract][Full Text] [Related]
2. Grafting using injectable calcium sulfate in bone tumor surgery: comparison with demineralized bone matrix-based grafting.
Kim JH; Oh JH; Han I; Kim HS; Chung SW
Clin Orthop Surg; 2011 Sep; 3(3):191-201. PubMed ID: 21909466
[TBL] [Abstract][Full Text] [Related]
3. Function after injection of benign bone lesions with a bioceramic.
Fillingham YA; Lenart BA; Gitelis S
Clin Orthop Relat Res; 2012 Jul; 470(7):2014-20. PubMed ID: 22290129
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of tibial plateau fractures with an injectable bone substitute: CERAMENT™. Three year follow-up from a prospective study.
Iundusi R; Gasbarra E; D'Arienzo M; Piccioli A; Tarantino U
BMC Musculoskelet Disord; 2015 May; 16():115. PubMed ID: 25968241
[TBL] [Abstract][Full Text] [Related]
5. The use of an injectable bone graft substitute in tibial metaphyseal fractures.
Watson JT
Orthopedics; 2004 Jan; 27(1 Suppl):s103-7. PubMed ID: 14763538
[TBL] [Abstract][Full Text] [Related]
6. The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial.
Kelly CM; Wilkins RM; Gitelis S; Hartjen C; Watson JT; Kim PT
Clin Orthop Relat Res; 2001 Jan; (382):42-50. PubMed ID: 11154003
[TBL] [Abstract][Full Text] [Related]
7. An injectable calcium sulfate-based bone graft putty using hydroxypropylmethylcellulose as the plasticizer.
Urban RM; Turner TM; Hall DJ; Infanger SI; Cheema N; Lim TH; Richelsoph K
Orthopedics; 2004 Jan; 27(1 Suppl):s155-9. PubMed ID: 14763550
[TBL] [Abstract][Full Text] [Related]
8. Long-term Follow-up of the Use of a Synthetic Bone Graft Composite in the Surgical Management of Primary Bone Tumors.
Multani I; Schneider P; Baldawi H; Deheshi B; Ghert M
Orthopedics; 2018 Nov; 41(6):e868-e875. PubMed ID: 30371921
[TBL] [Abstract][Full Text] [Related]
9. Use of a calcium sulfate-based bone graft substitute for benign bone lesions.
Gitelis S; Piasecki P; Turner T; Haggard W; Charters J; Urban R
Orthopedics; 2001 Feb; 24(2):162-6. PubMed ID: 11284599
[TBL] [Abstract][Full Text] [Related]
10. Use of a calcium sulfate-calcium phosphate synthetic bone graft composite in the surgical management of primary bone tumors.
Evaniew N; Tan V; Parasu N; Jurriaans E; Finlay K; Deheshi B; Ghert M
Orthopedics; 2013 Feb; 36(2):e216-22. PubMed ID: 23380017
[TBL] [Abstract][Full Text] [Related]
11. Natural Course of Local Bone Mineralization After Treatment of Benign or Borderline Bone Tumors and Cysts With a Composite Ceramic Bone Graft Substitute.
Horstmann PF; Hettwer WH; Petersen MM
J Clin Densitom; 2018; 21(4):472-479. PubMed ID: 29661685
[TBL] [Abstract][Full Text] [Related]
12. Calcium sulfate as bone graft substitute in the treatment of osseous bone defects, a prospective study.
Kumar C Y; K B N; Menon J; Patro DK; B H B
J Clin Diagn Res; 2013 Dec; 7(12):2926-8. PubMed ID: 24551676
[TBL] [Abstract][Full Text] [Related]
13. Healing bone lesion defects using injectable CaSO
Hall DJ; Turner TM; Urban RM
J Biomed Mater Res B Appl Biomater; 2019 Feb; 107(2):408-414. PubMed ID: 29663638
[TBL] [Abstract][Full Text] [Related]
14. Injectable Synthetic Beta-Tricalcium Phosphate/Calcium Sulfate (GeneX) for the Management of Contained Defects Following Curettage of Benign Bone Tumours.
Razii N; Docherty LM; Halai M; Mahendra A; Gupta S
Curr Oncol; 2023 Mar; 30(4):3697-3707. PubMed ID: 37185394
[TBL] [Abstract][Full Text] [Related]
15. The effect of allomatrix injectable putty on the outcome of long bone applications.
Wilkins RM; Kelly CM
Orthopedics; 2003 May; 26(5 Suppl):s567-70. PubMed ID: 12755227
[TBL] [Abstract][Full Text] [Related]
16. Unexpected radiographic lucency following grafting of bone defects with calcium sulfate/tricalcium phosphate bone substitute.
Auston DA; Feibert M; Craig T; Damron TA
Skeletal Radiol; 2015 Oct; 44(10):1453-9. PubMed ID: 26081807
[TBL] [Abstract][Full Text] [Related]
17. "Three-in-One minimally invasive approach to surgical treatment of pediatric pathological fractures with wide bone loss through bone cysts: ESIN, curettage and packing with injectable HA bone substitute. A retrospective series of 116 cases.".
Guida P; Ragozzino R; Sorrentino B; Casaburi A; D'Amato RD; Federico G; Guida L; Assantino A
Injury; 2016 Jun; 47(6):1222-8. PubMed ID: 27105837
[TBL] [Abstract][Full Text] [Related]
18. The effect of demineralized bone matrix-calcium sulfate with vancomycin on calcaneal fracture healing and infection rates: a prospective study.
Bibbo C; Patel DV
Foot Ankle Int; 2006 Jul; 27(7):487-93. PubMed ID: 16842714
[TBL] [Abstract][Full Text] [Related]
19. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial.
McKee MD; Wild LM; Schemitsch EH; Waddell JP
J Orthop Trauma; 2002 Oct; 16(9):622-7. PubMed ID: 12368641
[TBL] [Abstract][Full Text] [Related]
20. Treatment of unicameral bone cysts in pediatric patients with an injectable regenerative graft: a preliminary report.
Gentile JV; Weinert CR; Schlechter JA
J Pediatr Orthop; 2013; 33(3):254-61. PubMed ID: 23482260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
